test altFunding OpportunitiesAward ManagementComliance Review and OversightEducation and TrainingTechnology Transfer
Office of Research and Technology Management
Promoting Research, Advancing Scholarship, Fostering Innovation
Identify Funding Oportunities Proposal Development Award Management
Compliance Review and Oversight Education and Training Technology Transfer


Welcome from the Vice President for Research

CWRU researchers are among the most distinguished in the world. We have 16 Nobel Laureates among current and former faculty and alumni, 4 members of the National Academies of Sciences, 7 members of the National Academy of Engineering, and 8 members of the Institute of Medicine. We also partner with artistic and cultural institutions on a broad range of projects that make important scholarly contributions in the humanities and social sciences.

Extraordinary research requires an outstanding infrastructure. Our Office of Research & Technology Management provides support to seek out grant funding, to facilitate industrial sponsorship, and to transfer university technologies to the marketplace. This is a place for people driven to make a difference, and our office exists to help them succeed.

Contact us. We want you to see what our campus can offer.

Dr. Suzanne Rivera


Research Matters

Research Matters

Use the following link in order to view previous editions of Research Matters and Research News and Updates Research Matters Archive .




Latest News

Research Newsletter
May 14, 2015  

NIH Posts Reminder of Its Policy on Application Compliance

The National Institutes of Health (NIH) recently released a notice to remind applicants, both investigators and grants office officials, that to be fair to all concerned the NIH needs to consistently apply standards for application compliance.

In part, the notice states that NIH may withdraw any application identified during the receipt, referral and review process that is not compliant with the instructions in the SF 424 (R&R) Application Guide, the Funding Opportunity Announcement, and relevant NIH Guide Notices.

Examples of reasons an application may be withdrawn for non-compliance include:

  • inclusion of biosketchs that do not conform to the required format
  • applications that do not conform to page limit requirements
  • applications submitted as new but containing elements of a resubmission or renewal application
  • applications submitted after 5 pm local time
Read the full notice at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-095.html.

 
Good Clinical Practice (GCP) Certification

Tuesday, June 2, 2015
8:00AM – 11:30 AM
Wolstein Research Building Auditorium, Room 1413


8:00 – 10:00 AM- GCP and PI Responsibilities:
This session will include discussions of the relationships between laws, regulations, guidelines, and standard operating procedures. Key obligations of sponsors, monitors and investigators and their inter-relationships will be described. Investigators completing the program will receive a GCP certificate that can be provided to sponsors.

10:15 - 11:30 AM- Ethical Considerations, Informed Consent and Financial Disclosure:
This session will include a brief historical perspective of ethical considerations in conducting clinical research. The elements and process for obtaining informed consent from potential study participants will be discussed and well as financial disclosure.

Registration is online at: http://research.case.edu/Education/OnlineCalendar.cfm.

 
Department of Health and Human Services – Food & Drug Administration

The goal of this program is to support the advancement of regulatory science that can facilitate the implementation and the assessment of emerging manufacturing technology in the pharmaceutical sector. Emerging manufacturing technology can be viewed as a technology that has the potential to modernize the pharmaceutical manufacturing body of knowledge to support more robust, predictable, and/or cost-effective processes and with which the FDA has limited review or inspection experiences, due to its relative novelty. Examples of such elements include innovative or novel (1) product manufacturing technology, such as the dosage form; (2) manufacturing process (e.g., design, scale-up, and/or commercial scale); and/or (3) testing technology.

Application Deadline: June 30 , 2015

For more information visit the Grants.Gov webpage.

 
National Human Genome Research Institute (NHGRI)

The National Human Genome Research Institute (NHGRI) is soliciting grant applications for the support of Centers of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs). The CEER Program is designed to support the establishment of sustainable trans-disciplinary research teams with the expertise and flexibility to anticipate, conduct research on, and quickly address a range of cutting edge ethical, legal, and social issues related to genetics and genomics. The Program is intended to create new research opportunities that cross disciplinary boundaries among investigators in diverse fields, such as the genomic sciences, clinical research, clinical and health policy, ethics, law, the humanities, economics, political science, anthropology and other basic social sciences. In addition to conducting trans-disciplinary research, Centers will disseminate their research findings and engage in other activities that facilitate the utilization of their findings and deliberations in the development of research, health and public policies and practices regarding the use of genomic information and technologies. Finally, Centers will contribute to developing the next generation of ELSI researchers.

Letter of Intent Deadline: June 1, 2015 Application Deadline: July 15, 2015

For more information visit the NIH webpage.

 
Student Research - Responsibilities before Graduation

Before graduating students leave the university, it is important that the following research-related responsibilities are fulfilled:

  • Any student-initiated institutional review board (IRB) protocol is required either to be turned over to the responsible investigator or closed out with the IRB.Keep in mind that in order to close a protocol, data must be deidentified. If identifiable data will be retained, the protocol must remain open and the faculty investigator is responsible for keeping the data and maintaining the security measures of it, as outlined in the approved IRB protocol.

  • For student-related research that has been federally funded, faculty advisors and responsible/principal investigators must keep original data, and students may take copies, unless a formal written agreement is made that ensures immediate and complete access to the original data.

  • Upon terminating the IRB protocol, the student must provide copies of the completed informed consent documents and any data collection instruments to the responsible investigator.
For more information on custody of research data, please see Section C, 6: http://www.case.edu/president/facsen/frames/handbook/research_scholar.htm/.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.